Westlake Therapeutics
Hangzhou, China · Founded 2019 · $27.6M raised
- Headquarters
- Hangzhou
- Founded
- 2019
- Business Model
- B2B
- Website
- westlaketpx.com
- Total Funding
- $27.6M
- Last Round
- $13.8M Series AJun 2022
- Rounds
- 4
About
Biotech developing engineered red blood cell therapeutics for cancer, immunological, and metabolic diseases via its REDx platform.
Summary
Westlake Therapeutics is a Biotech company based in Hangzhou, China, founded in 2019. It has raised $27.6M in total across 4 rounds, most recently a $13.8M Series A round in Jun 2022. Investors include Westlake University and Eight Roads Ventures.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jun 2022
Sign up to see all 4 rounds
Pre-Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/westlake-therapeutics"><img src="https://indexed.vc/api/badge/company/westlake-therapeutics" alt="Westlake Therapeutics on Indexed.vc" width="260" height="76" /></a>